Search within the Lindenbaum website

Strategic thinking. Creative solutions. Pragmatic advice.

Our mission is to resolve our clients' disputes effectively and decisively.

We specialize in commercial litigation, antitrust litigation, corporate litigation, financial litigation and class actions. We look for amicable solutions where possible, and vigorously pursue our clients' claims when litigation is the best available option. Our clients are corporates, institutional investors, shareholders, management boards as well as groups of companies and consumers.

Read more

Lindenbaum is a litigation firm. We focus on what we do best: resolving disputes. We strategically enforce your rights by combining our expertise and experience with decisive action.

News & insights

Collective action on excessive pricing of pharmaceuticals moves on to merits phase

5 September 2024 - News

The Amsterdam District Court ruled that the representative organization Stichting Farma Ter Verantwoording is admissible in its collective action against pharmaceutical giant AbbVie. The case now moves on to the merits phase, in which the court will assess whether Abbvie abused its dominant position and violated human rights by charging excessive prices for its Humira medicine.

Read more

Amsterdam Court of Appeal provides key decision regarding WAMCA admissibility requirements

28 August 2024 - Insights

The Amsterdam Court of Appeal has provided guidance for future Dutch mass tort cases in its decision in the matter between The Privacy Collective and Oracle and Salesforce.

Read more

Recent developments in relation to the annulment of share purchases in the Netherlands

12 August 2024 - Publications

Lindenbaum partner Guido Vergouwen has published a case note in the Dutch law journal JIN on the Supreme Court case Rookie/ABC Hekwerk c.s. in relation to the annulment of share purchases.

Read more

Our people

Our attorneys are litigators with extensive experience, a focus on client service and a passion for advocating.

Meet the experts